AAAAAA
Results: 1-25/3357
Authors:
Andre, FE
Citation: Fe. Andre, Randomized, cross-over, controlled comparison of two inactivated hepatitisA vaccines, VACCINE, 20(3-4), 2001, pp. 292-293
Authors:
Arya, SC
Citation: Sc. Arya, Measles vaccine immunogenicity and antibody persistence in 12-vs. 15-month-old infants, VACCINE, 20(3-4), 2001, pp. 294-294
Authors:
Gil, A
Oyaguez, I
Carrasco, P
Gonzalez, A
Citation: A. Gil et al., Epidemiology of primary varicella hospitalizations in Spain, VACCINE, 20(3-4), 2001, pp. 295-298
Authors:
Gzyl, A
Augustynowicz, E
van Loo, I
Slusarczyk, J
Citation: A. Gzyl et al., Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland, VACCINE, 20(3-4), 2001, pp. 299-303
Authors:
Mooij, P
Heeney, JL
Citation: P. Mooij et Jl. Heeney, Rational development of prophylactic HIV vaccines based on structural and regulatory proteins, VACCINE, 20(3-4), 2001, pp. 304-321
Authors:
Brown, F
Citation: F. Brown, Inactivation of viruses by aziridines, VACCINE, 20(3-4), 2001, pp. 322-327
Authors:
Chang, HC
Lin, TL
Wu, CC
Citation: Hc. Chang et al., DNA-mediated vaccination against infectious bursal disease in chickens, VACCINE, 20(3-4), 2001, pp. 328-335
Authors:
Olander, RM
Wuorimaa, T
Kayhty, H
Leroy, O
Dagan, R
Eskola, J
Citation: Rm. Olander et al., Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers, VACCINE, 20(3-4), 2001, pp. 336-341
Authors:
Xing, D
Das, RG
O'Neill, T
Corbel, M
Dellepiane, N
Milstien, J
Citation: D. Xing et al., Laboratory testing of whole cell pertussis vaccine: a WHO proficiency study using the Kendrick test, VACCINE, 20(3-4), 2001, pp. 342-351
Authors:
de Kleijn, E
van Eijndhoven, L
Vermont, C
Kuipers, B
van Dijken, H
Rumke, H
de Groot, R
van Alphen, L
van den Dobbelsteen, G
Citation: E. De Kleijn et al., Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesiclevaccine, VACCINE, 20(3-4), 2001, pp. 352-358
Authors:
Da'dara, AA
Skelly, PJ
Wang, MM
Harn, DA
Citation: Aa. Da'Dara et al., Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice, VACCINE, 20(3-4), 2001, pp. 359-369
Authors:
Paoletti, LC
Peterson, DL
Legmann, R
Collier, RJ
Citation: Lc. Paoletti et al., Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen, VACCINE, 20(3-4), 2001, pp. 370-376
Authors:
Nakase, H
Okazaki, K
Tabata, Y
Uchida, K
Uose, S
Ohana, M
Nishi, T
Watanabe, T
Matsuura, M
Hisatsune, H
Matsumura, K
Itoh, T
Kawanami, C
Chiba, T
Citation: H. Nakase et al., Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination, VACCINE, 20(3-4), 2001, pp. 377-384
Authors:
Cunha, MG
Rodrigues, MM
Soares, IS
Citation: Mg. Cunha et al., Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP1(19) expressed in distinct bacterial vectors, VACCINE, 20(3-4), 2001, pp. 385-396
Authors:
Bolmstedt, A
Hinkula, J
Rowcliffe, E
Biller, M
Wahren, B
Olofsson, S
Citation: A. Bolmstedt et al., Enhanced immunogenicity of a human immunodeficiency virus type 1 env DNA vaccine by manipulating N-glycosylation signals - Effects of elimination of the V3N306 glycan, VACCINE, 20(3-4), 2001, pp. 397-405
Authors:
Turkstra, JA
Oonk, HB
Schaaper, WMM
Meloen, RH
Citation: Ja. Turkstra et al., The role of the individual amino acids of a GnRH-tandem-dimer peptide usedas an antigen for immunocastration of male piglets determined with systematic alanine replacements, VACCINE, 20(3-4), 2001, pp. 406-412
Authors:
Koesling, J
Lucas, B
Develioglou, L
Aebischer, T
Meyer, TF
Citation: J. Koesling et al., Vaccination of mice with live recombinant Salmonella typhimurium aroA against H-pylori: parameters associated with prophylactic and therapeutic vaccine efficacy, VACCINE, 20(3-4), 2001, pp. 413-420
Authors:
Niethammer, AG
Primus, FJ
Xiang, R
Dolman, CS
Ruehlmann, JM
Ba, Y
Gillies, SD
Reisfeld, RA
Citation: Ag. Niethammer et al., An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice, VACCINE, 20(3-4), 2001, pp. 421-429
Authors:
Poland, GA
Ovsyannikova, IG
Jacobson, RM
Vierkant, RA
Jacobsen, SJ
Pankratz, VS
Schaid, DJ
Citation: Ga. Poland et al., Identification of an association between HLA class II alleles and low antibody levels after measles immunization, VACCINE, 20(3-4), 2001, pp. 430-438
Authors:
Chlichlia, K
Bahgat, M
Ruppel, A
Schirrmacher, V
Citation: K. Chlichlia et al., DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice, VACCINE, 20(3-4), 2001, pp. 439-447
Authors:
Liese, JG
Stojanov, S
Berut, F
Minini, P
Harzer, E
Jow, S
Schodel, F
Boslego, J
Hoffenbach, A
Kronwitter, A
Belohradsky, BH
Citation: Jg. Liese et al., Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP similar to T-HBs) administered at 2, 4, 6 and 12-14 months of age, VACCINE, 20(3-4), 2001, pp. 448-454
Authors:
Ramirez, JR
Gilchrist, K
Robledo, S
Sepulveda, JC
Moll, H
Soldati, D
Berberich, C
Citation: Jr. Ramirez et al., Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice, VACCINE, 20(3-4), 2001, pp. 455-461
Authors:
Shi, FH
Zhang, YB
Ye, P
Lin, JJ
Cai, YM
Shen, W
Bickle, QD
Taylor, MG
Citation: Fh. Shi et al., Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China, VACCINE, 20(3-4), 2001, pp. 462-467
Authors:
Garly, ML
Bale, C
Martins, CL
Balde, MA
Hedegaard, KL
Whittle, HC
Aaby, P
Citation: Ml. Garly et al., BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens, VACCINE, 20(3-4), 2001, pp. 468-474
Authors:
Ohyama, H
Matsushita, S
Nishimura, F
Kato, N
Hatano, K
Takashiba, S
Murayama, Y
Citation: H. Ohyama et al., T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy, VACCINE, 20(3-4), 2001, pp. 475-482